ApiJect CEO Expects Therapy to Blunt Coronavirus Death Rate by Summer

Mar.26 — Jay Walker, ApiJect chairman and chief executive officer, says the company’s prefilled “soft syringes” will help in the coronavirus fight because they facilitate emergency work at a fast speed. He speaks with Bloomberg’s Vonnie Quinn, Sonali Basak and Guy Johnson on “Bloomberg Markets.”

Leave a Comment